Status:
COMPLETED
Effect of Tecar in Addition of Functional Massage in Post-stroke Spasticity
Lead Sponsor:
Universitat Internacional de Catalunya
Conditions:
Stroke Sequelae
Massage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Spasticity is due to an abnormal processing of a normal input from muscle spindles in the spinal cord.
Detailed Description
Stroke often affects sensory-motor networks and descending tracts, as reflected by several signs of upper motor neuron syndrome. One symptom is post-stroke spasticity. It is due to an abnormal process...
Eligibility Criteria
Inclusion
- Diagnosis of Stroke
- Scoring 1 on the Modified Ashworth Scale (MAS) for hip or/and knee flexion or/and ankle dorsiflexion on the most affected limb
- Scoring 25 or plus on the Montreal Cognitive Assessment (MoCA)
Exclusion
- Having suffered a traumatism on the lower limbs three months, or less, before the intervention
- Suffer other neurological disease
- Presence of osteosynthetic material
- Pacemaker wearing
- Treatment with botulinum toxin or another antispastic medication, six months , or less, before the intervention
- Carry baclofen pump
- Functional inability to adopt the prone or supine position on the treatment table
- Functional inability to sit, stand and walk
- Poor language and communication skills that make difficult to understand the informed consent
- Contraindications to Functional Massage (infectious diseases, inflammatory vascular conditions, acute inflammation, hemorrhagic, fever)
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 26 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04824768
Start Date
May 20 2021
End Date
May 26 2022
Last Update
March 29 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitat Internacional de Catalunya
Barcelona, Catalonia, Spain, 08195
2
Laura Garcia Rueda
Barcelona, Spain, 08440